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Abstract
There is a critical need for developing new malaria diagnostic tools that are sensitive, cost effective and capable of
performing large scale diagnosis. The real-time PCR methods are particularly robust for large scale screening and they can
be used in malaria control and elimination programs. We have designed novel self-quenching photo-induced electron
transfer (PET) fluorogenic primers for the detection of P. falciparum and the Plasmodium genus by real-time PCR. A total of
119 samples consisting of different malaria species and mixed infections were used to test the utility of the novel PET-PCR
primers in the diagnosis of clinical samples. The sensitivity and specificity were calculated using a nested PCR as the gold
standard and the novel primer sets demonstrated 100% sensitivity and specificity. The limits of detection for P. falciparum
was shown to be 3.2 parasites/ml using both Plasmodium genus and P. falciparum-specific primers and 5.8 parasites/ml for P.
ovale, 3.5 parasites/ml for P. malariae and 5 parasites/ml for P. vivax using the genus specific primer set. Moreover, the
reaction can be duplexed to detect both Plasmodium spp. and P. falciparum in a single reaction. The PET-PCR assay does not
require internal probes or intercalating dyes which makes it convenient to use and less expensive than other real-time PCR
diagnostic formats. Further validation of this technique in the field will help to assess its utility for large scale screening in
malaria control and elimination programs.
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Introduction
Four different Plasmodium species with different clinical implica-
tions infect humans in different combinations around the world,
with recent studies demonstrating that P. knowlesi is also capable of
causing human malaria due to zoonotic transmission [1].
Approximately 225 million cases of malaria and 781,000 deaths
due to malaria occurred in 2009 [2]. Due to the apparent decline
in the number of malaria cases and deaths in the last few years,
there is a concerted global effort to control and eliminate malaria
with the support of many public and private initiatives (reviewed in
[3,4]). Therefore, there is a clear need for diagnostic tools that are
robust enough to accurately detect the species of infecting
parasite(s), to identify the transmission foci of malaria reservoirs
(often which may be submicroscopic and asymptomatic) and to
monitor the success of malaria control and elimination programs.
The existing tools for malaria diagnosis include microscopy,
parasite antigen/enzyme detection kits [commonly referred to as
rapid diagnostic tests (RDTs)] and molecular tools (nucleic acid
based tools). Microscopy remains the gold standard for the
diagnosis of malaria in many malaria endemic countries. Although
microscopy is relatively inexpensive and can be used to
differentiate parasite species as well as provide quantitative data
on the level of parasitemia, several limitations including poor
sensitivity [5–9] begs for novel methods in the elimination era.
RDTs have become an alternative tool for malaria diagnosis.
While some RDTs are Plasmodium-specific, (pan) detecting the
genus-specific aldolase and lactate dehydrogenase enzymes, the
majority of the RDTs are specific for the P. falciparum histidine-rich
protein –2 (Pf HRP-2). The recent discovery that some P.
falciparum parasites in parts of South America and Africa have
deleted the hrp-2 gene [10,11] has brought into question the use of
the HRP-2 based RDT tests due to potential false negatives.
Another drawback of RDTs is the fact that they cannot be used to
determine parasite densities and such quantification is increasingly
essential with respect to both, antimalarial drug resistance
surveillance and malaria control programs. With limits of
detection at ,100 parasites/ml (reviewed in [12]), RDTs can only
be useful for routine diagnosis and treatment. With the limitations
of both microscopy and RDTs, there is a clear realization that
more sensitive diagnostic tools are needed for the detection of
subclinical but transmissible infections to guide and monitor
malaria elimination programs [13].
Molecular tools are far more sensitive in detecting low level
infections and accurately detecting species of malaria parasite
(reviewed in [5,12]). There are many versions of molecular tools
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for malaria diagnosis ranging from conventional PCR-based
assays, real-time PCR assays and more recently, isothermal
amplification assays (reviewed in [7,12]). When considering the
development of tools for large scale field application, it is desirable
to consider cost, robustness, and ease of use. The real-time PCR
platform has some advantages for large scale screening as it
requires no major post-PCR steps to acquire the results and a large
number of samples can be analyzed at one time.
Real-time PCR assays depend on the use of fluorophores or
DNA intercalating fluorescent dyes. As in the cases of TaqMan
probes, molecular beacons and scorpion, sequence-specific oligo-
nucleotide probes are dual labeled with a fluorescent dye and
quencher. Although these molecular methods are robust and
simpler than conventional PCR methods for large scale screening,
the reagents are expensive and require special handling, which
then creates practical challenges for field use in malaria endemic
countries. A less complicated real-time PCR technique is the use of
non-specific DNA intercalating dyes such as SYBR Green, SYTO-
9, and calcein, which emit fluorescence signals when bound to
double stranded DNA. Another drawback for these non-specific
intercalating dyes is that they do not allow for multiplexing. Other
alternatives for the detection of real-time PCR assays have been
described including the direct labeling of one of the primers
(forward or reverse) with a single fluorophore in a manner that
facilitates self-quenching without the need of a quencher. These
self-quenching primers facilitate the use of real-time PCR without
the need for internal dual-labeled sequence specific probes. An
example of this is the Light Upon Extension (LUX) primer that is
labeled with an internal single fluorophore near the 39 end of the
primer in a hairpin structure which allows for the quenching
before amplification [14]. These self-quenching, single labeled
primers are less expensive compared to the dual labeled probe.
However, the design of LUX primers requires the specific
software, LUX Designer.
Here we describe a novel method for labeling real-time PCR
primers based on the principle that was recently described in a
patent filed by Jothikumar et al. (patent # PCT/US2008/
084347). In this simplified technique, the 59 end of one of the
primers is modified by the addition of a 17-bases oligonucleotide
tail that is labeled with a fluorophore (HEX or FAM) on its 59 end,
(Figure 1). In the absence of amplification, this tail forms a loop
and remains in a closed conformation resulting in effective
quenching of fluorescence due to close proximity of four G bases
(i.e., the two overhang GG and two complementary GG residues
in the hairpin formation) via photo-induced electron transfer
(PET) mechanism; hence the name PET-PCR (not to be confused
with the PET fluorescence dye from ABI). When participating in
nucleic acid amplification, the stem loop structure of the PET
primer opens up. The subsequent fluorescence increase is due to
the de-quenching effect of the two guanosine residues located in
the overhang positions and also due to the formation of the
complementary DNA strand.
To evaluate this concept, we designed PET-PCR primers for
the specific amplification of the Plasmodium genus and P. falciparum
species. We demonstrate the utility of this assay using 119 clinical
samples of different malaria species infections, including mixed
infections, and using well quantified Plasmodium species to
estimate the limits of detection of this assay.
Materials and Methods
Ethics Statement
Some samples used in this study were obtained from a study
conducted in Kenya. This study was approved by both the Kenya
Medical Research Institute (KEMRI) and the CDC Institutional
Review Board and informed written consent forms were obtained
from each subject.
PET-PCR Primers
The design of the PET-PCR primers follows the same common
rules for PCR primer design. In this study the genus specific
primers were designed to amplify the 18S ribosomal RNA gene of
Plasmodium. The primers were designed based on GenBank
accession # GU815531; the P. malariae 18S small subunit
ribosomal RNA gene. A BLAST search was performed to
ascertain that the region selected for primer design was conserved
in the rest of the Plasmodia species. The target for the P. falciparum
specific primer set, Pfr364, was described previously [15]. In both
cases, the 59 end of the reverse primers was modified with the PET
tag and labeled with FAM (for the genus) and HEX (for P.
Figure 1. PET-PCR Primer design. The photo-induced electron
transfer (PET) primer consists of a quasi-universal tail sequence at 59 and
sequence specific region at 39. This 59 generic tail sequence consists of a
6 base pair stem, 3 nucleotide loop, a single fluorophore attached at 59
end and two deoxyguanosine located in the opposite overhang region.
The first two dangling end base on the PET primers are deoxyguanosine
located at first and second overhang position respectively provided the
greatest quenching in the absence of amplification. Circled FL is
fluorescence attached to 59. Z is sequence specific primer. X, ATA and Y
together form a loop like structure. X and Y are complementary
structure. Figure.1B. Fluorescence of PET primer increases during
amplification when an extension of the complementary strand takes
place. The result of fluorescence increase is due to dequenching effect
of deoxyguanosine located in overhang positions and due to the
formation of double strand.
doi:10.1371/journal.pone.0056677.g001
Table 1. Oligonucleotide primer sequences used in the real-
time PET-PCR assay.
Sequence (59-39) Position









The target independent tail (underlined) is attached to the 59end of the target
specific sequences and do not show any homology to Plasmodium spp.
sequences.
*Position based on GenBank accession # GU815531 for 18S small subunit
ribosomal RNA gene.
#Designed based on a previously described P. falciparum specific target, Pfr364 [15].
doi:10.1371/journal.pone.0056677.t001
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falciparum). These oligonucleotide primers for Plasmodium spp. and
P. falciparum are shown in Table 1.
Plasmodium Parasites and Clinical Samples
Different Plasmodium species available in our laboratories were
used in this study: P. falciparum (3D7, FCR3, W2, D6, Dd2, V1-S,
Nigeria, Santa Lucia), P. vivax (South Vietnam IV), P. malariae
(Uganda I), P. knowlesi (Nuri) and P. ovale (Nigeria I). DNA from 50
clinical samples available from the CDC molecular diagnostic
parasitology reference laboratory (Dr. A. DaSilva) (10 non-malaria
samples, 13 P. falciparum, 9 P. vivax, 1 P. malariae, 11 P. ovale, 2 P.
falciparum/P. malariae, 1 P. vivax/P. ovale, 2 P. falciparum/P. ovale
mixed infections and 1 P. knowlesi; parasitemia data not available)
were used. In addition, a set of 69 P. falciparum positive samples
from a study in Kenya were tested anonymously (microscopic
parasitemia range of 1230–231,040 parasites/ml).
DNA Extraction
DNA was isolated from all the samples using a QIAamp DNA
Mini Kit (QIAGEN, Valencia, CA-(Qiagen method)). The DNA
was aliquoted and stored at 220uC.
PET-PCR Method
Amplification of Plasmodium spp. or P. falciparum was performed
in a 20 ml reaction containing 2X TaqMan Environmental Master
Mix 2.0 (Applied BioSystems), 125 nM each forward and reverse
primer, and 2 ml of DNA template. The reactions were performed
under the following cycling parameters: initial hot-start at 95uC for
10 minutes, followed by 45 cycles of denaturation at 95uC for 10
seconds, annealing at 60uC. The correct fluorescence channel was
selected for each fluorescently labeled primer set and the cycle
threshold (CT) values recorded at the end of annealing step. Any
sample with a CT value of 40.5 or below was considered positive.
Both singleplex and multiplex assays were performed for all the
samples.
Nested PCR and Real-time PCR Methods for Comparison
Due to its superior sensitivity over microscopy and other
molecular tests, a nested PCR was chosen as a reference test to
calculate the sensitivity and specificity of the PET-PCR. The
nested PCR was performed with primers and cycling conditions as
described by Singh et al. [16] with some modifications. Reactions
were performed in a 20 ml total volume containing 1X buffer,
2.5 mM MgCl2, 200 mM dNTPs, 200 nM primers, and 1.25 units
Figure 2. Quantitative comparison of PET-PCR assay and Rougemont real-time PCR assay. The PET-PCR and Rougemont real-time PCR
assays were run using two well-quantified P. falciparum strains (Nigeria and Santa Lucia) used at six differing parasitemia levels (2000, 400, 80, 16, 3.2
and 0.64 parasites/ml). To determine the correlation between CT values and parasitemia, the mean CT values obtained in the PET-PCR assay (A) and in
the Rougemont real time PCR assay (B) were plotted against the log transformed parasitemia (Log parasitemia). The CT values demonstrated
reproducible linearity over the parasitemia range tested as both methods show significant correlation with R2 values .0.990. No statistical difference
in mean CT values was observed for the two different strains or for the two different methods (P.0.05).
doi:10.1371/journal.pone.0056677.g002
Table 2. Reproducibility of the singleplex and multiplex PET-PCR assays for P. falciparum detection.












Genus-S 29.1960.40 31.7060.67 33.9260.69 36.6960.57 39.5661.20 42.9261.02
Pf- S 28.2260.58 31.1160.36 33.3360.64 35.7160.39 37.7960.49 42.7760.77
Genus-M 28.1560.46 30.5060.88 33.0460.66 35.6960.31 38.5461.23 41.8961.23
Pf-M 27.6461.41 30.3260.63 33.0660.46 35.5560.47 37.9760.45 42.4060.81
A well-quantified P. falciparum strain (Nigeria strain) was used at six differing parasitemia levels (2000, 400, 80, 16, 3.2 and 0.64 parasites/ml). The reactions using the
genus-specific primers (Genus) and P. falciparum- specific primers (Pf) were performed both in the singleplex (Genus-S and Pf-S) and multiplex (Genus-M and Pf-M)
formats. The mean CT values 6 standard deviation (SD) obtained from three experiments each performed in duplicate are shown.
doi:10.1371/journal.pone.0056677.t002
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of Taq Polymerase (New England Biolabs, Ipswich, MA). The
PCR amplified material was analyzed using gel electrophoresis
(2% gel) to visualize the bands of appropriate size. Since the PET-
PCR assay is a real-time PCR assay, a well-known real-time PCR
diagnostic method developed by Rougemont et al. [17] (here after
referred as Rougemont real-time PCR) was chosen as an
additional method for making a quantitative comparison. The
Rougemont real-time PCR is a duplex PCR, capable of detecting
the four human infecting Plasmodium species in a set of two
simultaneous separate duplex reactions (P. falciparum duplexed with
P. vivax and P. malariae duplexed with P. ovale). For the comparison
in our study, only one duplex reaction was performed (P. falciparum
with P. vivax). This assay was performed as described by the
authors. Briefly, a 25 ml reaction containing 12.5 ml of TaqMan
Universal Master Mix (Applied Biosystems), 200 nM each of the
Plasmodium specific forward and reverse primers and 80 nM of the
species-specific probes was prepared. The assay was executed
using the following cycling conditions: an initial step at 50uC for
2 min, 95uC for 10 min, and 45 cycles of 95uC for 15 s and 60uC
for 1 min. A cut-off CT value of 40 was used to indicate a positive
result.
Test for Specificity, Sensitivity
The specificity of the primers was first tested by their ability to
correctly amplify the gene of interest. P. falciparum, P. vivax, P. ovale,
P. knowlesi and P. malariae DNA were used in the first round of
testing. In addition, geographically-diverse strains for P. falciparum
Table 3. Detection of mock mixed infections using the multiplex assay.






NTC No CT No CT






NTC No CT No CT






NTC No CT No CT
Mock mixed infections were prepared using a well-quantified P. falciparum strain (Nigeria strain) at five differing parasitemia levels (2000, 400, 80, 16 and 3.2 parasites/
ml) combined with varying parasite densities of P. malariae, P. vivax and P. ovale (as shown in the table). The mean CT values for the P. falciparum and genus primers sets
obtained from two experiments each performed in duplicate are shown. The multiplex assay was able to detect all the varying combinations of the mock-mixed
infections. NTC = no template control; SD = standard deviation.
doi:10.1371/journal.pone.0056677.t003
Table 4. Comparison of PET–PCR to nested PCR using clinical
samples.
Number of samples detected by each method (n)
Nested PCR Singleplex-PET Multiplex-PET
P. falciparum Genus P. falciparum Genus
P. falciparum (82) 80/80# 81/81# 81/82* 82/82
P. vivax (9) 0/9 9/9 0/8# 8/8#
P. ovale (11) 0/9# 9/9# 0/11 11/11
P. malariae (1) 0/1 1/1 0/1 1/1
P. knowlesi (1) 0/1 1/1 0/1 1/1
Pf/Po (2) 2/2 2/2 1/2* 2/2
Pf/Pm (2) 2/2 2/2 2/2 2/2
Pv/Po (1) 0/1 1/1 ND ND
Non-malaria (10) 0/8# 0/9# 0/10 0/10
A total of 119 clinical samples consisting of different malaria species and mixed
infections were used to test the utility of the PET-PCR primers in diagnosis of
clinical samples.
#Not all the samples tested by nested PCR were tested in all the PET-PCR assays
due to insufficient sample volumes.
*The P. falciparum primer (used in the multiplex assay) failed to detect two P.
falciparum positive samples.
ND = not done.
doi:10.1371/journal.pone.0056677.t004
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(3D7, FCR3, W2, D6, Dd2, and V1-S) and P.vivax were used to
test for specificity of the primers.
Analytical Sensitivity
The analytical sensitivity (limits of detection) of both the genus-
and falciparum-specific assays was determined using two well-
quantified P. falciparum strains (Nigeria and Santa Lucia). The
recommended WHO protocol for standards preparation used for
quality control of RDT tests was used to prepare the P. falciparum
standards (http://www.wpro.who.int/sites/rdt/using_rdts/qa/
lot_testing.htm). The P. falciparum parasites were at the ring or
early trophozoite stage of development when the sample was used
(to exclude multinucleated parasites contributing to quantitative
bias). The percent parasitemia was determined by three expert
microscopists by counting the number of parasites in approxi-
mately 2000 erythrocytes examined. The total number of
erythrocytes/ml was measured directly using a coulter counter
and the number of parasites/ml was calculated from the total
number of RBCs/ml and the percent parasitemia obtained. This
standard sample was then diluted from the initial parasitemia to
2000 parasites/ml using uninfected whole blood and was then
serial diluted fivefold to 0.64 parasite/ml using a 250 ml volume.
DNA was extracted from each dilution point using 200 ml of
sample. The analytical sensitivity of the PET-PCR assay was
compared to that of the nested PCR [16] and a previously
reported real-time PCR assay [17]. In addition, the limit of
detection of the genus primer set to detect P. ovale, P. malariae and
P. vivax was tested. These samples were kindly given to us by Dr.
John Barnwell, Malaria Branch, Centers for Disease Control and
Prevention (CDC).
Clinical Sensitivity and Specificity
The clinical sensitivity and specificity of the PET-PCR assay
was calculated using 119 clinical samples: 69 microscopically
positive P. falciparum samples from Kenya and 50 clinical samples
available from the CDC molecular diagnostic parasitology
reference laboratory which were previously tested for malaria
using the Rougemont real-time PCR assay. Microscopy data was
unavailable for these 50 clinical samples. A nested PCR assay [16]
was used as the reference test. The percentage specificity and
sensitivity were calculated as follows: Sensitivity = true positives/
(true positives+false negatives) 6100. Specificity = true negatives/
(true negatives+false positives) 6 100. In addition, 95% Confi-
dence Intervals (95% CI) for both sensitivity and specificity were
calculated.
Results
Detection of Different Plasmodium Species Using the
Genus-specific and P. falciparum-Specific PET- primers
In the initial round of testing we were able to amplify the five
human-infecting Plasmodium species (P. falciparum, P. vivax, P.
malariae, P. knowlesi and P. ovale) using the genus-specific primer set.
The P. falciparum specific primer set amplified P. falciparum only.
Both primer sets detected all the additional P. falciparum strains
tested (3D7, FCR3, W2, D6, Dd2, and V1-S). In addition, the
genus-specific primers detected 11 strains of P. vivax and 5 simian
Plasmodium species, P. cynomolgi, P. inui, P. simiovale, P. hylobati and
P. coatneyi.
Limits of Detection of PET-PCR Assay
The limits of detection of the genus and P. falciparum-specific
primer sets was tested using serial dilution of calibrated DNA stock
prepared from two P. falciparum strains (Nigeria and Santa Lucia).
The parasitemia ranged from 2000, 400, 80, 16, 3.2 and 0.64
parasites/ml which was diluted using whole blood and DNA
extracted for analysis. This was compared in parallel with the
Rougemont real-time PCR and the nested PCR. Using a CT
value of 40 as a cut off, both the PET-PCR and Rougemont real-
time PCR assays detected as low as 3.2 parasites/ml. This was
comparable to the nested PCR which consistently detected 3.2
parasites/ml and occasionally as few as 0.64 parasites/ml. The
limits of detection of the genus-specific primer set for the other
Plasmodium species was ascertained with DNA obtained from P.
vivax, P. ovale and P. malariae infected blood and determined to be
5.0 parasites/ml, 5.8 parasites/ml, and 3.5 parasites/ml, respective-
ly.
Quantitative Comparison of PET-PCR Assay and
Rougemont Real-time PCR Assay
The quantitative nature of the PET-PCR method was
compared in parallel with the Rougemont real-time PCR using
the P. falciparum serial dilutions utilized in testing the limits of
detection above. The obtained CT values were plotted against the
log transformed parasitemia to determine any correlation between
the two (Figure 2). Similar to the Rougemont real time PCR assay,
the CT values obtained in the PET-PCR assay demonstrated
reproducible linearity over the range of parasitemia tested in four
replicate experiments. Both methods showed significant correla-
tion with R2 values .0.990 and a significant correlation coefficient
(p,0.0007) for the mean CT values and parasitemia implying that
this method can be used to quantify parasitemia. No statistical
difference in mean CT values was observed for the two different
strains or for the two different methods (P.0.05).
Multiplex Assay
To test the possibility of multiplexing the assay, the two primer
sets were used in a duplex assay. A well-quantified P. falciparum
strain (Nigeria strain) was used at six differing parasitemia levels
(2000, 400, 80, 16, 3.2 and 0.64 parasites/ml). The reactions were
performed both in the singleplex and multiplex formats. Both the
singleplex and multiplex formats gave similar CT values for the
different parasitemia levels tested, Table 2. In addition, the assay
was performed using mock-mixed infections of P. falciparum/P.
vivax, P, falciparum/P. ovale and P. falciparum/P. malariae with varying
parasite densities of the P. falciparum. Both primer sets were able to
detect all the varying concentrations in the mock mixed infections,
Table 3.
Clinical Sensitivity and Specificity of the Plasmodium
Genus and P. falciparum Specific PET-primers
One hundred and nineteen clinical samples consisting of
different malaria species and mixed infections were used to test
the utility of the novel PET-PCR primers in diagnosis of clinical
samples. As shown in Table 4 all the P. falciparum samples tested
were shown to be positive by the P. falciparum–specific and the
Plasmodium -specific primer sets. The genus-specific primers
detected all other non-falciparum samples tested. No signal was
detected with the 10 non-malaria human DNA. The sensitivity
and specificity of these singleplex assays was calculated using the
nested PCR as a reference test. Both primer sets showed 100%
sensitivity and specificity. In the multiplex assays, the genus–
specific primers were able to accurately detect all the Plasmodium
spp. samples; however, the P. falciparum-specific primer set failed to
detect two P. falciparum samples (Table 4). Microscopy data was
only available for 69 P. falciparum samples. These samples
Malaria PET-PCR
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(parasitemia range of 1230–231,040 parasites/ml) were all shown
to be positive by both primers sets.
Discussion
The use of self-quenching real-time PCR primers using a 17-
base loop tail was recently described in a patent filed by
Jothikumar et al. (patent # PCT/US2008/084347). In this
proof-of-concept study, we designed PET-PCR primers for the
detection of Plasmodium spp. and P. falciparum and successfully
demonstrated that these primers can be duplexed to detect both
Plasmodium genus and P. falciparum species in a single tube. The
sensitivities of this assay are better than those reported for
microscopy and RDTs (reviewed in [18]), and comparable to that
of other real-time PCR assays (range from 0.7–10 parasites/ml)
[17,19,20]. As reviewed by Okell [5], the existence of submicro-
scopic infections is well documented and are known to contribute
to the infective reservoirs of malaria gametocytes [21–23].
Therefore, sensitive assays such as the PET-PCR described here,
that are capable of detecting submicroscopic infections are
valuable for any malaria control and elimination programs, as
these will help monitor transmission foci and dynamics as well as
control efforts. Moreover, this assay provides the option of
analyzing a large number of samples in a short time.
We demonstrate that PET-PCR is comparable to Rougemont
real-time PCR (a Taqman based assay which is widely used for
malaria diagnosis) both in terms of high sensitivity and the ability
to quantify parasitemia. To date, no self-quenching real-time PCR
assay has been described for malaria diagnosis. The self-quenching
in PET-PCR facilitates the use of real-time PCR without the need
for probe designs involving internal quenching thereby reducing
the cost of the assay by obviating the need for expensive probes
from commercial vendors. In addition, high-performance liquid
chromatography (HPLC) purification is not required for the single
labeled primer, resulting in a high yield of product further
reducing the costs as compared to the commonly used dual-labeled
probes. Furthermore, the PET-PCR primers can be either stored
in the refrigerator without loss of activity for up to a month or be
lyophilized and reconstituted when the end user is ready to use
them. These practical advantages together with the lower costs
and the easy design of PET primers (no specific software is
required) offers promising features that can enable the adoption of
this method as an alternate real-time PCR for malaria detection
for large scale screening of field samples in large malaria
surveillance and control programs.
The genus-specific assay described here offers an efficient, high-
throughput malaria detection tool, ideal for the screening of
malaria, irrespective of the species. This is useful, for example, in
surveillance/screening epidemiological studies. It can be used to
both monitor and evaluate malaria control programs in which
screening of malaria infection is necessary or as a confirmatory test
for detecting malaria infection. If desired, the PET-PCR can be
duplexed to detect genus and P. falciparum in one tube, albeit with
some slight loss of sensitivity for the P. falciparum-specific primers.
This is common with multiplex assays, which often require some
compromise of the components and assay conditions to accom-
modate two or more primer sets which can lead to primer
competition and loss of sensitivity. This caveat is not insurmount-
able as further improvements can be undertaken to address this
issue. However, while duplexing these primer sets is a possibility,
detection of mixed infections is not achievable because a positive
result with the genus primer only indicates that Plasmodium spp. is
present. Used together these two primer sets only indicates an
infection with P. falciparum and does not necessarily indicate the
lack of a mixed infection with other Plasmodium species. This is
the same caveat encountered in many of the commonly used
malaria RDTs that detect pan-Plasmodium antigens and the P.
falciparum specific HRP-2 protein. Development of primers to
detect non-falciparum species (P. vivax, P. malariae, P. ovale and P.
knowlesi) will be required to make this method applicable in clinical
laboratory settings.
Diagnostic tools for large scale field application need to be
cheaper, robust, and easy to use. The PET-PCR assay described
here meets these criteria and can be used for large scale screening
in surveillance and epidemiological studies including as a
confirmatory test in clinical laboratory settings.
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